Almost five million people in the UK have diabetes – and the number is rising. Counterweight, leaders in evidence-based weight management, came to us to help them expand their reach with an affordable programme that would help a broader population kick type 2 diabetes into remission.
Counterweight helps patients reach remission from type 2 diabetes using a meal replacement programme. It began as a research study in the University of Aberdeen 18 years ago and it has been scientifically proven to be ten times more effective than the current NHS protocol. After delivering this programme in Scotland via GPs for several years, Counterweight wanted to provide an affordable, direct-to-patient treatment offering.
Over 12 weeks, the team conducted in-depth research with patients and dietitians to understand every aspect of the journey and identify key pain points. We looked at the programme holistically, working on everything from brand design, service blueprints, to a working proof-of-concept prototype.
Counterweight is now widely used as a partner for diabetes treatment in NHS Scotland and is expanding successfully across the UK. Ultimately, it’s helping people with type 2 diabetes move into long-term remission.